TLX is a an oncogene and its expression defines a distinct subgroup of T cell acute lymphoblastic leukemia, being TLX1+ tumors prone to aneuploidy and showing marked defects in the activation of normal mitotic checkpoints [35]. The gene discussed is TLX1; the disease is T-cell acute lymphoblastic leukemia.